Regeneron Reports Results of REGEN-COV (casirivimab and imdevimab) in P-III Study Against COVID-19
Shots: The P-III trial evaluates REGEN-COV (1200mg, SC) vs PBO in a ratio (1:1) in patients who lived in the same household with COVID-19 patients […]